Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Synthesis and antitumor activity of a series of osmium(VI) nitrido complexes bearing quinolinolato ligands.

Tang Q, Ni WX, Leung CF, Man WL, Lau KK, Liang Y, Lam YW, Wong WY, Peng SM, Liu GJ, Lau TC.

Chem Commun (Camb). 2013 Nov 4;49(85):9980-2. doi: 10.1039/c3cc42250j.

PMID:
24042270
2.

Reactivity of nitrido complexes of ruthenium(VI), osmium(VI), and manganese(V) bearing Schiff base and simple anionic ligands.

Man WL, Lam WW, Lau TC.

Acc Chem Res. 2014 Feb 18;47(2):427-39. doi: 10.1021/ar400147y. Epub 2013 Sep 18.

PMID:
24047467
3.

A breast cancer stem cell-selective, mammospheres-potent osmium(VI) nitrido complex.

Suntharalingam K, Lin W, Johnstone TC, Bruno PM, Zheng YR, Hemann MT, Lippard SJ.

J Am Chem Soc. 2014 Oct 15;136(41):14413-6. doi: 10.1021/ja508808v. Epub 2014 Oct 6.

4.

Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathways.

Suntharalingam K, Johnstone TC, Bruno PM, Lin W, Hemann MT, Lippard SJ.

J Am Chem Soc. 2013 Sep 25;135(38):14060-3. doi: 10.1021/ja4075375. Epub 2013 Sep 16.

5.

A SAR study of novel antiproliferative ruthenium and osmium complexes with quinoxalinone ligands in human cancer cell lines.

Ginzinger W, Mühlgassner G, Arion VB, Jakupec MA, Roller A, Galanski M, Reithofer M, Berger W, Keppler BK.

J Med Chem. 2012 Apr 12;55(7):3398-413. doi: 10.1021/jm3000906. Epub 2012 Mar 27.

PMID:
22417128
6.

Ruthenium(II) and osmium(II) 1,2,3-triazolylidene organometallics: a preliminary investigation into the biological activity of 'click' carbene complexes.

Kilpin KJ, Crot S, Riedel T, Kitchen JA, Dyson PJ.

Dalton Trans. 2014 Jan 21;43(3):1443-8. doi: 10.1039/c3dt52584h. Epub 2013 Nov 8.

PMID:
24201979
7.

From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands.

Hanif M, Meier SM, Kandioller W, Bytzek A, Hejl M, Hartinger CG, Nazarov AA, Arion VB, Jakupec MA, Dyson PJ, Keppler BK.

J Inorg Biochem. 2011 Feb;105(2):224-31. doi: 10.1016/j.jinorgbio.2010.10.004. Epub 2010 Oct 14.

PMID:
21194622
8.

Antitumor effects of a tetradentate amido-carboxylate ligands and corresponding square-planar palladium(II) complexes toward some cancer cells. Crystal structure, DFT modeling and ligand to DNA probe docking simulation.

Matović ZD, Mrkalić E, Bogdanović G, Kojić V, Meetsma A, Jelić R.

J Inorg Biochem. 2013 Apr;121:134-44. doi: 10.1016/j.jinorgbio.2013.01.006. Epub 2013 Jan 16.

PMID:
23376555
9.

En route to osmium analogues of KP1019: synthesis, structure, spectroscopic properties and antiproliferative activity of trans-[Os(IV)Cl4(Hazole)2].

Büchel GE, Stepanenko IN, Hejl M, Jakupec MA, Keppler BK, Arion VB.

Inorg Chem. 2011 Aug 15;50(16):7690-7. doi: 10.1021/ic200728b. Epub 2011 Jul 8.

10.

Crystal structure and cytotoxic activity of Co(II) complex containing N,N'-tetra-(4-antipyrylmethyl)-1,2-diaminoethane (TAMEN) as ligand.

Mosoarca EM, Pantenburg I, Tudose R, Meyer G, Alexandrova R, Kalfin R, Linert W, Costişor O.

Med Chem. 2010 Sep;6(5):298-305.

PMID:
21073434
11.

Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.

Hanif M, Nazarov AA, Hartinger CG, Kandioller W, Jakupec MA, Arion VB, Dyson PJ, Keppler BK.

Dalton Trans. 2010 Aug 21;39(31):7345-52. doi: 10.1039/c003085f. Epub 2010 Jul 2.

PMID:
20601976
12.

Ruthenium- and osmium-arene-based paullones bearing a TEMPO free-radical unit as potential anticancer drugs.

Arion VB, Dobrov A, Göschl S, Jakupec MA, Keppler BK, Rapta P.

Chem Commun (Camb). 2012 Sep 4;48(68):8559-61. doi: 10.1039/c2cc33786j. Epub 2012 Jul 16.

PMID:
22797078
13.

Alkyl substituted 2'-benzoylpyridine thiosemicarbazone chelators with potent and selective anti-neoplastic activity: novel ligands that limit methemoglobin formation.

Stefani C, Jansson PJ, Gutierrez E, Bernhardt PV, Richardson DR, Kalinowski DS.

J Med Chem. 2013 Jan 10;56(1):357-70. doi: 10.1021/jm301691s. Epub 2012 Dec 31.

PMID:
23276209
14.

Organometallic osmium arene complexes with potent cancer cell cytotoxicity.

Fu Y, Habtemariam A, Pizarro AM, van Rijt SH, Healey DJ, Cooper PA, Shnyder SD, Clarkson GJ, Sadler PJ.

J Med Chem. 2010 Nov 25;53(22):8192-6. doi: 10.1021/jm100560f. Epub 2010 Oct 26.

PMID:
20977192
15.

High antitumor activity of 5,7-dihalo-8-quinolinolato cerium complexes.

Chen ZF, Wei JH, Liu YC, Liu M, Gu YQ, Huang KB, Wang M, Liang H.

Eur J Med Chem. 2013 Oct;68:454-62. doi: 10.1016/j.ejmech.2013.08.007. Epub 2013 Aug 13.

PMID:
23995094
16.

Novel methylene modified cyclohexyl ethylenediamine-N,N'-diacetate ligands and their platinum(IV) complexes. Influence on biological activity.

Mihajlović LE, Savić A, Poljarević J, Vučković I, Mojić M, Bulatović M, Maksimović-Ivanić D, Mijatović S, Kaluđerović GN, Stošić-Grujičić S, Miljković Đ, Grgurić-Šipka S, Sabo TJ.

J Inorg Biochem. 2012 Apr;109:40-8. doi: 10.1016/j.jinorgbio.2012.01.012. Epub 2012 Jan 31.

PMID:
22369771
17.

Synthesis and in vitro antitumor activity of novel iridium(III) complexes with enantiopure C2-symmetrical vicinal diamine ligands.

Yang Q, Chang J, Song J, Qian MT, Yu JM, Sun X.

Bioorg Med Chem Lett. 2013 Aug 15;23(16):4602-7. doi: 10.1016/j.bmcl.2013.06.024. Epub 2013 Jun 19.

PMID:
23849808
18.

Synthesis, crystal structure, cytotoxicity and DNA interaction of 5,7-dichloro-8-quinolinolato-lanthanides.

Chen ZF, Gu YQ, Song XY, Liu YC, Peng Y, Liang H.

Eur J Med Chem. 2013 Jan;59:194-202. doi: 10.1016/j.ejmech.2012.10.037. Epub 2012 Nov 12.

PMID:
23220648
19.

Antileukemic activity and cellular effects of rhodium(III) crown thiaether complexes.

Bieda R, Kitanovic I, Alborzinia H, Meyer A, Ott I, Wölfl S, Sheldrick WS.

Biometals. 2011 Aug;24(4):645-61. doi: 10.1007/s10534-011-9414-9. Epub 2011 Jan 28.

PMID:
21274738
20.

Cancer cell cytotoxicity of cyclometalated compounds obtained with osmium(II) complexes.

Boff B, Gaiddon C, Pfeffer M.

Inorg Chem. 2013 Mar 4;52(5):2705-15. doi: 10.1021/ic302779q. Epub 2013 Feb 21.

PMID:
23427955

Supplemental Content

Support Center